Subscribe
shutterstock_521453077_rolandmagnusson
Roland Magnusson / Shutterstock.com
17 August 2020Big PharmaSarah Morgan

EU reaches first COVID-19 vaccine deal

The European Commission reached its first agreement to supply EU member states with an experimental COVID-19 vaccine with  AstraZeneca late last week.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
EU concludes COVID-19 vaccine talks with Pfizer
10 September 2020   The European Commission has concluded exploratory talks with Pfizer and BioNTech to potentially supply 300 million doses of their investigational vaccine against COVID-19.
Americas
PureShield sues over COVID-19 disinfectant
30 September 2020   Antimicrobial company PureShield has accused its competitor Allied BioScience of infringing ten patents through the sale of a surface disinfectant, which claims protection against COVID-19 for up to seven days.
Americas
Milestone COVID-19 vaccine offers 90% protection
10 November 2020   A coronavirus vaccine unveiled by pharmaceutical companies Pfizer and BioNTech can potentially prevent more than 90% of people from getting COVID-19, it has been announced.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Big Pharma
EU concludes COVID-19 vaccine talks with Pfizer
10 September 2020   The European Commission has concluded exploratory talks with Pfizer and BioNTech to potentially supply 300 million doses of their investigational vaccine against COVID-19.
Americas
PureShield sues over COVID-19 disinfectant
30 September 2020   Antimicrobial company PureShield has accused its competitor Allied BioScience of infringing ten patents through the sale of a surface disinfectant, which claims protection against COVID-19 for up to seven days.
Americas
Milestone COVID-19 vaccine offers 90% protection
10 November 2020   A coronavirus vaccine unveiled by pharmaceutical companies Pfizer and BioNTech can potentially prevent more than 90% of people from getting COVID-19, it has been announced.

More on this story

Big Pharma
EU concludes COVID-19 vaccine talks with Pfizer
10 September 2020   The European Commission has concluded exploratory talks with Pfizer and BioNTech to potentially supply 300 million doses of their investigational vaccine against COVID-19.
Americas
PureShield sues over COVID-19 disinfectant
30 September 2020   Antimicrobial company PureShield has accused its competitor Allied BioScience of infringing ten patents through the sale of a surface disinfectant, which claims protection against COVID-19 for up to seven days.
Americas
Milestone COVID-19 vaccine offers 90% protection
10 November 2020   A coronavirus vaccine unveiled by pharmaceutical companies Pfizer and BioNTech can potentially prevent more than 90% of people from getting COVID-19, it has been announced.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility